BiTE antibody AMG 910
Term · Oncology and biomedicine · MLC-T-ONC-012048
A half-life extended (HLE), bispecific T-cell engager (BiTE) antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 910 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.
| Identifier | MLC-T-ONC-012048 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | bispecific T-cell engager AMG 910; bispecific T-cell engager antibody AMG 910; bispecific antibody AMG 910 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012048",
"term": "BiTE antibody AMG 910",
"field": "Oncology and biomedicine",
"definition": "A half-life extended (HLE), bispecific T-cell engager (BiTE) antibody that simultaneously binds to two different and as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, AMG 910 targets and binds to the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.",
"synonyms": [
"bispecific T-cell engager AMG 910",
"bispecific T-cell engager antibody AMG 910",
"bispecific antibody AMG 910"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/bite-antibody-amg-910/"
}
Record 3,631 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.